Targeted Drug Duo with Lighter Chemotherapy Delivers 97% Survival in Early-Stage Hodgkin Lymphoma
A phase 2 trial found that brentuximab vedotin and nivolumab added to limited chemotherapy produced a 92 percent complete response ...
A phase 2 trial found that brentuximab vedotin and nivolumab added to limited chemotherapy produced a 92 percent complete response ...
Injecting healthy mitochondria from stem cells into aged mice restored cardiac function by reactivating a blocked mitochondrial waste-disposal pathway controlled ...
A retrospective study of 66 cats treated with the anthracycline chemotherapy drug epirubicin found that side effects were mostly mild ...
A retrospective Australian cohort study found that a more than twelvefold increase in doxorubicin concentration during conventional transarterial chemoembolization produced ...
Researchers found that elongating stem cell membrane-coated mesoporous silica nanoparticles into rod shapes dramatically improves their diffusion, blood-brain barrier crossing, ...
A UC Davis clinical trial found that doxorubicin lymphodepletion before inhaled interleukin-15 therapy did not improve response rates in dogs ...
A prospective study of seven dogs with cancer shows that doxorubicin exposure varies far more between patients than within them, ...
New research shows that the TGF-β2 signaling molecule steers metastatic colon cancer cells toward autophagy-mediated resistance to the chemotherapy drug ...
New research shows that the immune checkpoint protein CD47 rises in doxorubicin-damaged hearts and that blocking it with an antibody ...
Researchers have created PNIPAM-coated hollow gold-silver nanoparticles that convert near-infrared light into heat to accelerate doxorubicin release, achieving synergistic chemo-photothermal ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine